Ibn Alhaytham Hospital (AMM:IBNH) Growth Rank: 0 (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:IBNH Ibn Alhaytham Hospital AMM:IBNH
27 GF Score
Price JOD0.82
GF Value JOD0.81
! 8 Warning Signs
View Full Analysis

What is Ibn Alhaytham Hospital Growth Rank?

Ibn Alhaytham Hospital has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Ibn Alhaytham Hospital Growth Rank Related Terms

AMM:IBNH
27GF Score
Ibn Alhaytham Hospital AMM:IBNH
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?

Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued. The current stock price of JOD0.82 is trading 1.2% above its estimated GF Value™ of JOD0.81.

Key valuation signals for AMM:IBNH:

  • Growth Rank: 0
  • GF Value™: JOD0.81 vs. price of JOD0.82 (1.2% above fair value)
  • GF Score™: 27/100 with 8 warning signs

No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ibn Alhaytham Hospital Business Description

Address Al-Madina Al-Monawara Street, Amman, JOR, 11194
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
27GF Score

Get the complete analysis for AMM:IBNH

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD0.82
Price
JOD0.81
GF Value